Hangzhou Minsheng Healthcare Co (SZSE:301507) COGS-to-Revenue : 0.37 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hangzhou Minsheng Healthcare Co COGS-to-Revenue?

Hangzhou Minsheng Healthcare Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥87.3 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥234.6 Mil.

Hangzhou Minsheng Healthcare Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Hangzhou Minsheng Healthcare Co's Gross Margin % for the three months ended in Mar. 2024 was 62.81%.

Hangzhou Minsheng Healthcare Co COGS-to-Revenue Historical Data

The historical data trend for Hangzhou Minsheng Healthcare Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Minsheng Healthcare Co COGS-to-Revenue Chart

Hangzhou Minsheng Healthcare Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.33

0.35

0.34

0.39

0.38

Hangzhou Minsheng Healthcare Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial									0.36	0.42	0.33	0.41	0.37

Hangzhou Minsheng Healthcare Co COGS-to-Revenue Calculation

Hangzhou Minsheng Healthcare Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	220.639	/	581.733
	=	0.38

Hangzhou Minsheng Healthcare Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	87.256	/	234.624
	=	0.37

Hangzhou Minsheng Healthcare Co (SZSE:301507) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Hangzhou Minsheng Healthcare Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	87.256 / 234.624
	=	62.81 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Hangzhou Minsheng Healthcare Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hangzhou Minsheng Healthcare Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Minsheng Healthcare Co (SZSE:301507) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 101, Xintian Road, Donghu Street, Linping, Zhejiang, Hangzhou, CHN, 311100

Website

http://www.21vita.com

Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).

Hangzhou Minsheng Healthcare Co (SZSE:301507) Headlines

No Headlines